BridgeBio Oncology Therapeutics, Inc. (BBOT)
NASDAQ: BBOT · Real-Time Price · USD
7.40
-0.29 (-3.77%)
Jun 26, 2026, 4:00 PM EDT - Market closed
BBOT Employees
BridgeBio Oncology Therapeutics had 106 employees as of March 31, 2026. The number of employees increased by 14 or 15.22% since the number was last reported on December 31, 2025.
Employees
106
Change
14
Growth
15.22%
Revenue / Employee
n/a
Profits / Employee
-$1,453,726
Market Cap
592.79M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 106 | 14 | 15.22% |
| Dec 31, 2025 | 92 | 30 | 48.39% |
| Dec 31, 2024 | 62 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Ginkgo Bioworks Holdings | 485 |
| 4D Molecular Therapeutics | 196 |
| CorMedix | 191 |
| AgomAb Therapeutics NV | 62 |
| Tectonic Therapeutic | 60 |
| Faeth Therapeutics | 29 |
| Achieve Life Sciences | 28 |
| Monopar Therapeutics | 22 |
BBOT News
- 5 days ago - BridgeBio Oncology assumed with an Outperform at Oppenheimer - TheFly
- 10 days ago - BridgeBio Oncology Therapeutics Transcript: AGM 2026 - Transcripts
- 6 weeks ago - BBOT Reports First Quarter 2026 Financial Results and Update on Corporate Progress - GlobeNewsWire
- 6 weeks ago - BridgeBio Oncology Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 6 weeks ago - BridgeBio Oncology Therapeutics Earnings release: Q1 2026 - Filings
- 6 weeks ago - BridgeBio Oncology Therapeutics Quarterly report: Q1 2026 - Filings
- 6 weeks ago - BridgeBio Oncology initiated with a Buy at Canaccord - TheFly
- 6 weeks ago - BridgeBio Oncology initiated with a Buy at Canaccord - TheFly